Topotecan

Hycamtin, Topotecan, Topotecan Hospira (topotecan) is a small molecule pharmaceutical. Topotecan was first approved as Hycamtin on 1996-05-28. It is used to treat non-small-cell lung carcinoma, ovarian neoplasms, small cell carcinoma, small cell lung carcinoma, and uterine cervical neoplasms in the USA. It has been approved in Europe to treat ovarian neoplasms, small cell lung carcinoma, and uterine cervical neoplasms. Topotecan hydrochloride's patent is valid until 2024-12-10 (FDA).